Retatrutide+​Cagrilintide Blend

The Reta-Cagri blend brings two metabolic research peptides together in a single lyophilised vial: Retatrutide, characterised as a GLP-1, GIP and glucagon triple receptor agonist, and Cagrilintide, a long-acting amylin analogue. Supplying them together lets a researcher reconstitute and study both under identical laboratory conditions. NOX provides it as a research reference material for research use only, and none of this information is medical or human-use guidance.

The incretin pathway that Retatrutide is studied through and the amylin pathway that Cagrilintide is studied through are frequently described as complementary in metabolic-signalling research, which is why amylin analogues and incretin agonists are sometimes examined together. A single vial lets researchers work with both from one reconstitution under the same preparation and storage conditions. This is a practical laboratory consideration only; the blend is supplied for research use only.

Each vial is a lyophilised blend of 20 mg Retatrutide and 5 mg Cagrilintide, for 25 mg of total peptide. The stated masses are the amount sealed in the vial before reconstitution; the working concentration of each depends on the volume of solvent a researcher adds during preparation. It is supplied as a research reference material for research use only.

The blend is referenced in metabolic and energy-balance research, where the two peptides it contains are each studied for receptor signalling, appetite-related pathways and body-weight pathways in laboratory and preclinical models. The focus is mechanism rather than any outcome in humans. As a NOX research reference material, it is supplied for research use only and carries no medical claim.

Lyophilised Retatrutide+​Cagrilintide Blend is supplied as a sealed, freeze-dried powder and is generally kept frozen and away from light, typically stored at around -20°C for long-term stability, while for shorter periods it can be kept in the fridge at 2–8°C. Keeping the vial sealed limits moisture uptake and helps preserve the dry material. This describes general laboratory handling of lyophilised research compounds and is provided for research use only, not as guidance for any other use.

Bacteriostatic water is commonly used to reconstitute lyophilised research compounds because the small amount of benzyl alcohol it contains helps limit microbial growth in a multi-use vial. It simply dissolves the freeze-dried powder into a liquid so the material can be handled in the laboratory. Reconstitution is performed strictly within a research context; Retatrutide+​Cagrilintide Blend is supplied by NOX for research use only.

Once reconstituted, Retatrutide+​Cagrilintide Blend is in solution and generally less stable than the dry powder, so the liquid is typically kept in the fridge at 2–8°C and protected from light. Researchers usually prepare only what a study requires and record the reconstitution date. This reflects general laboratory handling of reconstituted research materials and is offered for research-use-only context, not as guidance for human or veterinary use.

Yes. Retatrutide+​Cagrilintide Blend is supplied by NOX strictly as a research reference material for laboratory and analytical use. It is not a medicinal product, food, cosmetic or veterinary product, and nothing in these answers should be read as guidance for human or animal use. All information here is provided for educational and research context only.